Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
248,899
-
Share change
-
+73,298
-
Total reported value
-
$11,283,000
-
Put/Call ratio
-
240%
-
Price per share
-
$45.37
-
Number of holders
-
18
-
Value change
-
+$3,462,492
-
Number of buys
-
11
-
Number of sells
-
3
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q2 2018
As of 30 Jun 2018,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
248,899 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), Virtu Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP, LLC, BANQUE PICTET & CIE SA, Traynor Capital Management, Inc., Capital Analysts, LLC, WOLVERINE TRADING, LLC, and UBS Group AG.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.